Early and Sustained Virological Response in Non-Responders with Chronic Hepatitis CA Randomized Open-Label Study of Pegylated Interferon-α-2a versus Pegylated Interferon-α-2b

被引：0
|
作者：
Gaetano Scotto
Vincenzina Fazio
Chiara Fornabaio
Alessandra Tartaglia
Rocco Di Tullio
Annalisa Saracino
Gioacchino Angarano
机构：
[1] University of Foggia,Clinic of Infectious Diseases
[2] Hospital of Foggia,Clinical Chemistry Laboratory
来源：
Drugs | 2008年 / 68卷
关键词：
Viral Load; Sustained Virological Response; Early Virological Response; Viral Kinetic; Standard Interferon;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objectives: The purpose of this randomized open-label study was to assess the efficacy of treatment with pegylated interferon-α-2a versus pegylated interferon-α-2b, both plus ribavirin, in inducing early and sustained virological response (EVR and SVR) in chronic hepatitis C non-responders.
引用
收藏
页码：791 / 801
页数：10
相关论文
共 50 条
  • [1] Early and sustained virological response in non-responders with chronic hepatitis C -: A randomized open-label study of pegylated interferon-α-2a versus pegylated interferon-α-2b
    Scotto, Gaetano
    Fazio, Vincenzina
    Fornabaio, Chiara
    Tartaglia, Alessandra
    Di Tullio, Rocco
    Saracino, Annalisa
    Angarano, Gioacchino
    DRUGS, 2008, 68 (06) : 791 - 801
  • [2] Pegylated Interferon-α2a and Ribavirin versus Pegylated Interferon-α2b and Ribavirin in Chronic Hepatitis CA Meta-Analysis
    Nicolas Flori
    Natalie Funakoshi
    Yohan Duny
    Jean-Christophe Valats
    Michael Bismuth
    Dimitri Christophorou
    Jean-Pierre Daurès
    Pierre Blanc
    Drugs, 2013, 73 : 263 - 277
  • [3] Differential Antiviral Effects of Pegylated Interferon-α2a and Pegylated Interferon-α2b in Chronic Hepatitis C
    Durante-Mangoni, Emanuele
    Parrella, Antonio
    Iossa, Domenico
    Andini, Roberto
    Molaro, Rosa
    Battimelli, Carminia
    Sodano, Giuseppe
    Utili, Riccardo
    CLINICAL DRUG INVESTIGATION, 2014, 34 (12) : 871 - 878
  • [4] Differential Antiviral Effects of Pegylated Interferon-α2a and Pegylated Interferon-α2b in Chronic Hepatitis C
    Emanuele Durante-Mangoni
    Antonio Parrella
    Domenico Iossa
    Roberto Andini
    Rosa Molaro
    Carminia Battimelli
    Giuseppe Sodano
    Riccardo Utili
    Clinical Drug Investigation, 2014, 34 : 871 - 878
  • [5] Pegylated Interferon-α2a and Ribavirin versus Pegylated Interferon-α2b and Ribavirin in Chronic Hepatitis C A Meta-Analysis
    Flori, Nicolas
    Funakoshi, Natalie
    Duny, Yohan
    Valats, Jean-Christophe
    Bismuth, Michael
    Christophorou, Dimitri
    Daures, Jean-Pierre
    Blanc, Pierre
    DRUGS, 2013, 73 (03) : 263 - 277
  • [6] Pegylated interferon-α2a versus pegylated interferon-α2b in hepatitis C: reappraisal of effectiveness on the basis of trial sequential analysis
    Messori, Andrea
    Fadda, Valeria
    Maratea, Dario
    Trippoli, Sabrina
    Marinai, Claudio
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 26 (02) : 246 - 248
  • [7] Treatment of chronic hepatitis delta with pegylated interferon-α2b
    Erhardt, Andreas
    Gerlich, Wolfram
    Starke, Christine
    Wend, Ulrike
    Donner, Andreas
    Sagir, Abdurrahman
    Heintges, Tobias
    Haeussinger, Dieter
    LIVER INTERNATIONAL, 2006, 26 (07) : 805 - 810
  • [8] Efficacy and Tolerability of Pegylated Interferon-α2a plus Ribavirin versus Pegylated Interferon-α2b plus Ribavirin in Treatment-Naive Chronic Hepatitis C Patients
    Lee, Seok
    Kim, In Hee
    Kim, Seong Hun
    Kim, Sang Wook
    Lee, Seung Ok
    Lee, Soo Teik
    Kim, Dae Ghon
    Lee, Chang Seop
    Choi, Chang Soo
    Cho, Eun Young
    Kim, Haak Cheoul
    INTERVIROLOGY, 2010, 53 (03) : 146 - 153
  • [9] Soluble interleukin 2 receptor plasma levels in non-responders with chronic hepatitis C treated with pegylated interferon-α 2b and ribavirin
    Henke, H
    Schmiegel, W
    Brechmann, T
    Voigt, E
    Griga, T
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2004, 38 (03) : 301 - 303
  • [10] Interferon-α-2b+ribavirin for the treatment of chronic hepatitis C in non-responders to interferon-α-monotherapy
    Tromm, A
    Greving, I
    Griga, T
    Mankel, K
    Hüppe, D
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2000, 38 (02): : 159 - 164
12345